Advagene Biopharma Co (ROCO:6709) Market Cap : NT$1,259.77 Mil (As of May. 25, 2024)

Advagene Biopharma Co Market Cap Chart

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial										2,368.48	1,769.58	1,482.93	1,554.49	1,398.56

Competitive Comparison of Advagene Biopharma Co's Market Cap

For the Biotechnology subindustry, Advagene Biopharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's Market Cap falls into.

Advagene Biopharma Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Advagene Biopharma Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Advagene Biopharma Co's Market Cap for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advagene Biopharma Co  (ROCO:6709) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Advagene Biopharma Co Market Cap Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description